EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma

Jacob M Siewert iD, Daniel L Gustafson, Kristen M Weishaar iD, Annie M Galloway, Douglas H Thamm iD

Journal of Veterinary Internal Medicine · 01.11.2023 · 37 (6) · 2402-2409

DOI: 10.1111/jvim.16875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 01.11.2023. Verfasst von Jacob M Siewert und 4 weiteren Autor:innen. Beteiligte Einrichtung: Flint Animal Cancer Center, Colorado State University, Fort Collins, Colorado, USA. Hauptthemen laut MEDLINE: Lymphoma, Neutropenia, Dog Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eldred Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study was performed to determine the ability to escalate drug doses in a 15-week CHOP protocol in dogs with multicentric lymphoma. Hypothesis We hypothesized that at least 50% of dogs could successfully be escalated in at least 1 drug. Secondary aims were to establish objective response rate (ORR), progression-free interval (PFI), and overall survival time (OST). Animals Thirty dogs with newly diagnosed multicentric lymphoma were prospectively treated with a 15-week CHOP protocol.

Methods

This was a prospective cohort study. Drug doses that did not cause dose-limiting adverse effects (AEs) were increased using a standardized escalation protocol. AEs and response were assessed using VCOG criteria. Serial blood samples were collected after the first dose of each drug for pharmacokinetic analysis.

Results

Of the 23 dogs with the opportunity to dose escalate, at least 1 drug was successfully escalated in 18 (78%). Vincristine was successfully escalated to 0.8 mg/m2 or higher in 11 dogs, cyclophosphamide to 300 mg/m2 or higher in 16 dogs, and doxorubicin to 35 mg/m2 or 1.4 mg/kg or higher in 9 dogs. Three of the 23 dogs (13%) were hospitalized at least once because of drug-induced AEs. Neutropenia was the most common dose-limiting toxicosis for all drugs. Peak doxorubicin concentrations were significantly lower in dogs where doxorubicin was successfully escalated. The objective response rate was 100%. The median progression free interval was 171 days. The median overall survival time was 254 days.

Conclusions

Drugs in the CHOP protocol can often be escalated safely with manageable AEs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphomaNeutropeniaDog DiseasesHumansDogsAnimalsProspective StudiesDoxorubicin

Stichwörter der Autor:innen

CHOPadverse effectscancerpharmacokinetics

Substanzen

Doxorubicin

Autor:innen und Institutionen

  • Flint Animal Cancer Center, Colorado State University, Fort Collins, Colorado, USA.
  • University of Colorado Comprehensive Cancer Center, Aurora, Colorado, USA.
  • Colorado Animal Specialty & Emergency, Boulder, Colorado, USA.

ORCID-Profile: Jacob M Siewert, Kristen M Weishaar, Douglas H Thamm

Förderung

  • Eldred Foundation

Zitieren

APA

Siewert, J. M., Gustafson, D. L., Weishaar, K. M., Galloway, A. M., & Thamm, D. H. (2023). Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma. Journal of Veterinary Internal Medicine, 37(6), 2402-2409. https://doi.org/10.1111/jvim.16875

Vancouver

Siewert JM, Gustafson DL, Weishaar KM, Galloway AM, Thamm DH. Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma. Journal of Veterinary Internal Medicine. 2023;37(6):2402-2409. doi:10.1111/jvim.16875

BibTeX
@article{Siewert2023,
  author = {Siewert, Jacob M and Gustafson, Daniel L and Weishaar, Kristen M and Galloway, Annie M and Thamm, Douglas H},
  title = {Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2023},
  volume = {37},
  number = {6},
  pages = {2402--2409},
  doi = {10.1111/jvim.16875}
}
Kostenlos starten →